<SEC-DOCUMENT>0001047469-19-006929-index.html : 20191220 <SEC-HEADER>0001047469-19-006929.hdr.sgml : 20191220 <ACCEPTANCE-DATETIME>20191220171851 ACCESSION NUMBER: 0001047469-19-006929 CONFORMED SUBMISSION TYPE: 424B5 PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20191220 DATE AS OF CHANGE: 20191220 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics plc CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B5 SEC ACT: 1933 Act SEC FILE NUMBER: 333-223739 FILM NUMBER: 191302625 BUSINESS ADDRESS: STREET 1: 56 FITZWILLIAM SQUARE CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: (610) 816-6640 MAIL ADDRESS: STREET 1: 1000 CONTINENTAL DRIVE STREET 2: SUITE 600 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 FORMER COMPANY: FORMER CONFORMED NAME: Nabriva Therapeutics AG DATE OF NAME CHANGE: 20150507 </SEC-HEADER> <DOCUMENT> <TYPE>424B5 <SEQUENCE>1 <FILENAME>a2240337z424b5.htm <DESCRIPTION>424B5 <TEXT> Document 1 - file: a2240337z424b5.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>2 <FILENAME>g69145.jpg <DESCRIPTION>G69145.JPG <TEXT> Document 2 - file: g69145.jpg
</DOCUMENT> </SEC-DOCUMENT>